High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial - Schwartz, G G; Chaitman, B R; Goldberger, J J (Am Heart J, 2011)
et al.